About this study: This study is done to see if the new medicine called semaglutide can help people with early Alzheimer’s disease. This will be done by comparing semaglutide against placebo on the effect on cognition and daily functioning. Who can participate in this study? To be eligible...
About this study: The APOLLOE4 Study is testing an investigational drug to find out whether it may slow the progression of Alzheimer’s disease. At this time there are no approved drugs that halt or arrest the clinical decline typical of Alzheimer’s disease. The study drug is an...
About this study: Agitation is a common and serious problem among people living with Alzheimer’s dementia. This Aspect® clinical study involves researchers who want to find out if an investigational drug, AVP-786, is safe and effective (useful) in managing agitation in adults with Alzheimer’s dementia, when...
About this study: If you or your loved one has early stage Alzheimer’s Disease (AD), you may be eligible for this study. This study is evaluating an investigational drug called BPN14770 as a possible treatment for patients with early stage AD....
About this study: If you or your loved one has early stage Alzheimer’s Disease (AD), you may be eligible for this study. This study is evaluating an investigational drug called BPN14770 as a possible treatment for patients with early stage AD....
Palm Beach Neurological Center is participating in a clinical trial to examine if an investigational drug may help slow or stop memory loss in people with early stages of Alzheimer’s disease. It is an “Investigational” drug, meaning it has not yet been approved by regulatory...
Description Palm Beach Neurological Center is participating in a clinical research study to evaluate an investigational drug called “Delphia” for patients suffering from Dementia with Lewy Bodies. An investigational drug is not yet approved for use by the public. Doctors perform these studies to make sure...
Description A study to evaluate an investigational drug designed to inhibit receptors that are believed to contribute to migraine attacks. This study lasts up to 55 weeks, in which participants will be screened, go through two phases of treatment and have a follow-up visit. Study Treatment Phase –...
Several treatments are available to help ease Alzheimer’s symptoms; however, none of these existing treatments are capable of slowing the progression of the disease and protecting the brain from further damage. Clinical researches are developing new treatments that may slow the progression of Alzheimer’s. The SUVN-502...